Cachexia versus sarcopenia

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 1, 2011, Pages 15-21

  Rolland, Yves ^a,b   Van Kan, Gabor Abellan ^a,b   Gillette Guyonnet, Sophie ^a,b   Vellas, Bruno ^a,b  

^a INSERM   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Cachexia; Definition; Elderly; Sarcopenia

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGING; ARTICLE; CACHEXIA; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE METABOLISM; WALKING SPEED; WEIGHT REDUCTION;

CACHEXIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; METABOLIC DISEASES; MUSCLE, SKELETAL; SARCOPENIA;

EID: 79851509096     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328340c2c2     Document Type: Article

References (39)

1. Glass DJ. Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Meta Care 2010; 13:225-229.
2. Kung T, Springer J, Doehner W, et al. Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference. Expert Opin Investig Drugs 2010; 19:579-585.
3. Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr 2008; 27:793-799.
4. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and precachexia: joint document elaborated by Special Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and 'nutrition in geriatrics'. Clin Nutr 2010; 29:154-159.
5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39:412-423.
6. Bhasin S, Espeland MA, Evans WJ, et al. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci 2009; 64:487-491.
7. Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13:1-7.
8. Eleazer GP, McRae T, Knebl J, et al. Core competencies for the care of older patients: recommendations of American Geriatrics Society. Acad Med 2000; 75:252-255. (Pubitemid 30155293)
9. Chang HH, Tsai SL, Chen CY, Liu WJ. Outcomes of hospitalized elderly patients with geriatric syndrome: reportofa community hospital reform plan in Taiwan. Arch Gerontol Geriatr 2010; 50:S30-S33.
10. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50:889-896. (Pubitemid 34496687)
11. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147:755-763. (Pubitemid 28183275)
12. Gale CR, Martyn CN, Cooper C, Sayer AA. Grip strength, body composition, and mortality. Int J Epidemiol 2007; 36:228-235. (Pubitemid 47061603)
13. Evans WJ, LambertCP. Physiological basis of fatigue. Am J Phys Med Rehabil 2007; 86:S29-S46.
14. Ribaudo JM, Cella D, Hahn EA, et al. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 2000; 9:1137-1146. (Pubitemid 32452957)
15. Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009; 13:881-889.
16. Clark BC, Manini TM. Functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Meta Care 2010; 13:271-276.
17. Clark BC, Manini TM. Sarcopenia ≠ dynapenia. J Gerontol A Biol Sci Med Sci 2008; 63:829-834.
18. Cesari M, Pahor M, Lauretani F, et al. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 2009; 64:377-384.
19. Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 2009; 90:1579-1585.
20. Buchner DM, Larson EB, Wagner EH, et al. Evidence for a nonlinear relationship between leg strength and gait speed. Age Ageing 1996; 25:386-391. (Pubitemid 26381771)
21. Morley JE. Anorexia, weight loss, and frailty. J Am Med Dir Assoc 2010; 11:225-228.
22. Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm - issues and controversies. J Gerontol A Biol Sci Med Sci 2007; 62:731-737. (Pubitemid 350143604)
23. Doran P, Donoghue P, O'Connell K, et al. Proteomics of skeletal muscle aging. Proteomics 2009; 9:989-1003.
24. Symons TB, Sheffield-Moore M, Chinkes DL, et al. Artificial gravity maintains skeletal muscle protein synthesis during 21 days simulated microgravity. J Appl Physiol 2009; 107:34-38.
25. Kortebein P, Ferrando A, Lombeida J, et al. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 2007; 297:1772-1774. (Pubitemid 46658661)
26. Ferrando AA, Tipton KD, Bamman MM, Wolfe RR. Resistance exercise maintains skeletal muscle protein synthesis during bed rest. J Appl Physiol 1997; 82:807-810. (Pubitemid 27123259)
27. Paddon-Jones D, Sheffield-Moore M, Urban RJ, et al. Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab 2004; 89:4351-4358. (Pubitemid 39244437)
28. Lemmey AB, Marcora SM, Chester K, etal. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum 2009; 61:1726-1734.
29. Bruunsgaard H, Bjerregaard E, Schroll M, Pedersen BK. Muscle strength following resistance training is inversely correlated with baseline levels of soluble tumor necrosis Factor receptors in the oldest old. J Am Geriatr Soc 2004; 52:237-241. (Pubitemid 38233486)
30. Nieto-Vazquez I, Fernández-Veledo S, Krämer DK, et al. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 2008; 114:183-194. (Pubitemid 352009305)
31. Roubenoff R. Molecular basis of inflammation: relationships between catabolic cytokines, hormones, energy balance, and muscle. J Parenter Enteral Nutr 2008; 32:630-632.
32. Argilés JM, Busquets S, Felipe A, López-Soriano FJ. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol 2005; 37:1084-1104. (Pubitemid 40311748)
33. Thomas D. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007; 26:389-399. (Pubitemid 47091483)
34. Brinkley TE, Leng X, Miller ME, et al. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci 2009; 64:455-461.
35. Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline ofphysical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002; 50:1947-1954. (Pubitemid 35462439)
36. Lazar MA. How obesity causes diabetes: not a tall tale. Science 2005; 307:373-375. (Pubitemid 40139971)
37. Attaixa B, Baracos VR. MAFbx/atrogin-1 expression is a poor index of muscle proteolysis. Curr Opin Clin Nutr Meta Care 2010; 13:223-224.
38. Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 2008; 1782:730-743.
39. Lagirand-Cantaloube J, Cornille K, Csibi A, et al. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One 2009; 4:e4973.